JI
Congress trade
Sen. James Inhofe (R-OK) bought $15K-$50K of Bristol-Myers Squibb Company (BMY) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Bristol-Myers Squibb Company (BMY) stock worth $15K-$50K in a STOCK Act filing on Aug 9, 2016.
The trade happened on Aug 8, 2016, 1 day before it was made public.
BMY has moved +1.4% since the trade date, from $60.30 to $61.15 (Oct 2, 2026 close).
- Traded
- Aug 8, 2016
- Disclosed
- Aug 9, 2016
- Filing delay
- 1 day
- Price since
- +1.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (2)
More BMY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.